MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cellsig.2026.112509

Медицинская библиотека · Cellular signalling · 2026

The role of the triggering receptor expressed on myeloid cells family in metabolic syndrome: A review.

Li Yao, Wang Yaoyao, Li Hui, Gao Rongjing, Zhang Wei, Yang Xiancong

СтатьяОбзорПеревод в очереди

Аннотация

Metabolic syndrome (MetS) is a cluster of highly interrelated metabolic disorders, characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, which collectively elevate the risk of developing type 2 diabetes, cardiovascular diseases, and non-alcoholic fatty liver disease. Chronic low-grade inflammation is a key pathological driver in the initiation and progression of MetS, wherein the abnormal activation of monocytes and macrophages plays a pivotal role. The Triggering Receptors Expressed on Myeloid cells (TREMs) family serves as a critical bridge connecting innate immune responses with metabolic regulation. Within this family, TREM2, distinct from the pro-inflammatory TREM1, exhibits a tissue-protective phenotype, primarily involved in maintaining tissue homeostasis, promoting damage repair, and suppressing excessive inflammatory responses. In recent years, the crucial role of TREM2 in obesity-associated metabolic disturbances has been gradually elucidated. In high-fat diet-induced obesity models, TREM2 has been identified as a core marker and functional regulator of "lipid-associated macrophages (LAMs)" within adipose tissue, deeply involved in lipid droplet phagocytosis, cholesterol metabolic reprogramming, and the homeostasis of the local inflammatory microenvironment. This review systematically summarizes the diverse functions of TREM2 in metabolic syndrome, with a focus on analyzing its molecular mechanisms of action in adipose tissue, liver, and the vascular system. It explores its potential value as a disease biomarker and prospects the development of novel therapeutic strategies targeting the TREM2 signaling pathway, thereby providing new insights and a theoretical foundation for the treatment of metabolic diseases.

Для цитирования: Li Yao, Wang Yaoyao, Li Hui, Gao Rongjing, Zhang Wei, Yang Xiancong. The role of the triggering receptor expressed on myeloid cells family in metabolic syndrome: A review.. Cellular signalling. 2026. DOI: 10.1016/j.cellsig.2026.112509.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.